WO2005000099A3 - BLOOD FACTOR DOMAINS (BFDs) - Google Patents
BLOOD FACTOR DOMAINS (BFDs) Download PDFInfo
- Publication number
- WO2005000099A3 WO2005000099A3 PCT/US2004/018461 US2004018461W WO2005000099A3 WO 2005000099 A3 WO2005000099 A3 WO 2005000099A3 US 2004018461 W US2004018461 W US 2004018461W WO 2005000099 A3 WO2005000099 A3 WO 2005000099A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bfds
- blood factor
- factor domains
- diseases
- domains
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/297,134 US20060111297A1 (en) | 2004-06-09 | 2005-12-08 | Blood factor domains |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47729103P | 2003-06-09 | 2003-06-09 | |
US60/477,291 | 2003-06-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005000099A2 WO2005000099A2 (en) | 2005-01-06 |
WO2005000099A3 true WO2005000099A3 (en) | 2005-09-15 |
Family
ID=33551700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/018461 WO2005000099A2 (en) | 2003-06-09 | 2004-06-09 | BLOOD FACTOR DOMAINS (BFDs) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005000099A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007084388A2 (en) * | 2006-01-12 | 2007-07-26 | Sessa William C | Nogo-b receptor |
WO2011100197A1 (en) * | 2010-02-12 | 2011-08-18 | Ngm Biopharmaceuticals, Inc. | Methods of treating glucose metabolism disorders |
US20160030518A1 (en) * | 2013-04-03 | 2016-02-04 | The Regents Of The University Of California | Compositions and methods for inhibiting viral activity |
JP6625627B2 (en) * | 2014-10-14 | 2019-12-25 | ハロザイム インコーポレイテッド | Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using the same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034626A1 (en) * | 1999-11-05 | 2001-05-17 | Human Genome Sciences, Inc. | 28 human secreted proteins |
-
2004
- 2004-06-09 WO PCT/US2004/018461 patent/WO2005000099A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034626A1 (en) * | 1999-11-05 | 2001-05-17 | Human Genome Sciences, Inc. | 28 human secreted proteins |
Also Published As
Publication number | Publication date |
---|---|
WO2005000099A2 (en) | 2005-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006020269A3 (en) | Biomarkers of neurodegenerative disease | |
WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
WO2003047420A3 (en) | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors | |
AU2002327308A1 (en) | Methods for evaluating pathologic conditions using extracellular rna | |
WO2004112589A3 (en) | Method for the detection of gene transcripts in blood and uses thereof | |
EP1687283A4 (en) | Method and composition useful for determining fk 506 | |
WO2004055519A3 (en) | Specific markers for pancreatic cancer | |
WO2006078911A3 (en) | Gitr antibodies for the diagnosis of nsclc | |
WO2006024466A3 (en) | Test device for the in vitro diagnosis of multi-analyte tests and the use thereof | |
WO2009132058A3 (en) | Levels of bcma protein expression on b cells and use in diagnostic methods | |
DE602007011566D1 (en) | Ankheit | |
WO2008063479A3 (en) | Pancreatic cancer biomarkers | |
WO2005044990A3 (en) | Use of differentially expressed nucleic acid sequences as biomarkers for cancer | |
WO2006031926A3 (en) | Methods for the isolation and expansion of cord blood derived t regulatory cells | |
WO2004096985A3 (en) | Methods for assessing biologic diversity | |
WO2006092610A3 (en) | Markers for melanoma | |
WO2006085121A3 (en) | Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders | |
WO2010041046A3 (en) | Granin proteins as markers of heart disease | |
WO2009101059A3 (en) | Methods of using cadherin 11 (cdh11) antagonists | |
WO2004067570A3 (en) | Prostate cancer diagnosis and treatment | |
WO2003048333A3 (en) | Endorepellin compositions and methods for inhibiting angiogenesis | |
WO2007132120A3 (en) | Procedure and methods for detecting alzheimer's disease | |
WO2005124358A3 (en) | Diagnosis and treatment of siglec-6 associated diseases | |
WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
WO2002080844A3 (en) | Novel bgp compounds for therapy and diagnosis and methods for using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11297134 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |